The DOI matches its Crossref record; 1,155 of the 1,155 references it cites were found in a registry or an index.
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Abstract
Neurodegenerative diseases pose a substantial socioeconomic burden on society. Unfortunately, the aging world population and lack of effective cures foreshadow a negative outlook. Although a large amount of research has been dedicated to elucidating the pathologies of neurodegenerative diseases, their principal causes remain elusive. Metal ion dyshomeostasis, proteopathy, oxidative stress, and neurotransmitter deficiencies are pathological features shared across multiple neurodegenerative disorders. In addition, these factors are proposed to be interrelated upon disease progression. Thus, the development of multifunctional compounds capable of simultaneously interacting with several pathological components has been suggested as a solution to undertake the complex pathologies of neurodegenerative diseases. In this review, we outline and discuss possible therapeutic targets in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis and molecules, previously designed or discovered as potential drug candidates for these disorders with emphasis on multifunctionality. In addition, underrepresented areas of research are discussed to indicate new directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 801–1,000 of 1,155
Shodai, A., Morimura, T., Ido, A., Uchida, T., Ayaki, T., Takahashi, R., Kitazawa, S., Suzuki, S., Shirouzu, M., Kigawa, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451849 · Cited by 101
Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
Hosokawa, M., Arai, T., Masuda‐Suzukake, M., Nonaka, T., Yamashita, M., Akiyama, H., & Hasegawa, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052389 · Cited by 101
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 101
Self-citationMutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level
Atrián‐Blasco, E., Conte‐Daban, A., & Hureau, C. (2017) · Dalton Transactions · doi:10.1039/c7dt01344b · Cited by 101
Ray, B., B. Chauhan, N., & K. Lahiri, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796504664 · Cited by 100
Wang, Q., Zhang, X., Chen, S., Zhang, X., Zhang, S., Youdium, M. B. H., & Le, W. (2011) · Neurodegenerative Diseases · doi:10.1159/000323469 · Cited by 100
Sang, Z., Li, Y., Qiang, X., Xiao, G., Liu, Q., Tan, Z., & Deng, Y. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.005 · Cited by 100
Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Finsterwald, C., Magistretti, P. J., & Lengacher, S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710144502 · Cited by 100
The NMDA receptor ion channel: a site for binding of huperzine A
Gordon, R. K., Nigam, S. V., Weitz, J. A., Dave, J. R., Doctor, B. P., & Ved, H. S. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.805 · Cited by 100
Kannan, R., Chakrabarti, R., Tang, D., Kim, K. J., & Kaplowitz, N. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02184-8 · Cited by 99
Gluck, M. R., & Zeevalk, G. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02747.x · Cited by 99
Myricetin: A Naturally Occurring Regulator of Metal‐Induced Amyloid‐β Aggregation and Neurotoxicity
DeToma, A. S., Choi, J., Braymer, J. J., & Lim, M. H. (2011) · ChemBioChem · doi:10.1002/cbic.201000790 · Cited by 99
Self-citationBoyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J., Pierce Jr., W. M., Klein, J. B., Ferguson, J., Link, C. D., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.001 · Cited by 98
Li, S., Wang, X., Xie, S., Jiang, N., Wang, K. D. G., Yao, H., Sun, H., & Kong, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.024 · Cited by 98
Pisani, L., Catto, M., Leonetti, F., Nicolotti, O., Stefanachi, A., Campagna, F., & Carotti, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797379302 · Cited by 98
Alpha-synuclein modulates dopamine neurotransmission
Butler, B., Sambo, D. O., & Khoshbouei, H. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.06.001 · Cited by 98
Mompeán, M., Romano, V. C., Pantoja‐Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775965 · Cited by 98
Rasagiline (TVP-1012): A new selective monoamine oxidase inhibitor for Parkinson's disease
Guay, D. R. P. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.12.001 · Cited by 97
Kański, J., Aksenova, M. V., Schöneich, C., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00821-3 · Cited by 97
Li, S., Jiang, N., Xie, S., Wang, K. D. G., Wang, X., & Kong, L. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42010h · Cited by 97
DECREASED RATIO OF CSF ACETYLCHOLINESTERASE TO BUTYRYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE
Arendt, T., Bigl, V., Walther, F., & Sonntag, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90116-8 · Cited by 96
Singer, T. P., Ramsay, R. R., McKeown, K., Trevor, A., & Castagnoli, N. E. (1988) · Toxicology · doi:10.1016/0300-483x(88)90169-2 · Cited by 96
Sun, Q., Peng, D., Yang, S., Zhu, X., Yang, W., & Yang, G. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.057 · Cited by 96
Hung, K.-C., Huang, H.-J., Wang, Y.-T., & Lin, A. M.-Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.040 · Cited by 96
Rosini, M., Simoni, E., Minarini, A., & Melchiorre, C. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1250-1 · Cited by 95
Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease
Rajasekhar, K., Suresh, S., Manjithaya, R. R., & Govindaraju, T. (2015) · Scientific Reports · doi:10.1038/srep08139 · Cited by 95
Cell Degeneration Induced by Amyloid-β Peptides: Implications for Alzheimer's Disease
Pereira, C., Ferreiro, E. B., Cardoso, S. M., & Oliveira, C. R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:097 · Cited by 94
Bar‐Am, O., Amit, T., Kupershmidt, L., Aluf, Y., Mechlovich, D., Kabha, H., Danovich, L., Zurawski, V. R., Youdim, M. B. H., & Weinreb, O. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.026 · Cited by 94
Serdons, K., Terwinghe, C. Y., Vermaelen, P., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013376 · Cited by 94
Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., & Barnham, K. J. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.119909 · Cited by 93
Sang, Z., Qiang, X., Li, Y., Yuan, W., Liu, Q., Shi, Y., Ang, W., Luo, Y., Tan, Z., & Deng, Y. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.063 · Cited by 93
Desideri, N., Bolasco, A., Fioravanti, R., Monaco, L. P., Orallo, F., Yáñez, M., Ortuso, F., & Alcaro, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013709 · Cited by 93
Beck, M. W., Derrick, J. S., Kerr, R. A., Oh, S. B., Cho, W. J., Lee, S. J. C., Ji, Y., Han, J., Tehrani, Z. A., Suh, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms13115 · Cited by 93
Self-citationLink of impaired metal ion homeostasis to mitochondrial dysfunction in neurons
Nam, E., Han, J., Suh, J., Yi, Y., & Lim, M. H. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.09.009 · Cited by 93
Self-citationXu, P., Zhang, M., Sheng, R., & Ma, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.045 · Cited by 92
Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10
Shi, J., Qian, W., Yin, X., Iqbal, K., Grundke, I., Gu, X., Ding, F., Gong, C., & Liu, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204453 · Cited by 92
Li, Y., Qiang, X., Luo, L., Xia, Y., Xiao, G., Zheng, Y., Cao, Z., Sang, Z., Su, F., & Deng, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.048 · Cited by 92
Wang, Z., Hu, J., Yang, X., Feng, X., Li, X., Huang, L., & Chan, A. S. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01417 · Cited by 91
Choi, J. W., Jang, B. K., Cho, N., Park, J., Yeon, S. K., Ju, E. J., Lee, Y. S., Han, G., Pae, A. N., Kim, D. J., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.012 · Cited by 91
Differentiating Alzheimer disease-associated aggregates with small molecules
Honson, N. S., Johnson, R. L., Huang, W., Inglese, J., Austin, C. P., & Kuret, J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.018 · Cited by 91
Ma, Q., Hu, J. N., Wu, W., Liu, H., Du, J., Fu, Y., Wu, Y., Lei, P., Zhao, Y., & Li, Y. (2006) · Biopolymers · doi:10.1002/bip.20523 · Cited by 91
Prati, F., Bergamini, C., Fato, R., Soukup, O., Korábečný, J., Andrisano, V., Bartolini, M., & Bolognesi, M. L. (2016) · ChemMedChem · doi:10.1002/cmdc.201600014 · Cited by 91
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells
Molina‐Holgado, F., Gaeta, A., Francis, P. T., Williams, R. J., & Hider, R. C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05332.x · Cited by 90
Koleva, Y. K., Madden, J. C., & Cronin, M. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8002438 · Cited by 90
Peptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90
Guo, L., Guan, Z.-Z., Huang, Y., Wang, Y., & Shi, J. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2012.05.003 · Cited by 90
Rabal, O., Sánchez-Arias, J. A., Cuadrado‐Tejedor, M., de Miguel, I., Pérez-González, M., García, C., Ugarte, A., de Mendoza, A. E., Sáez, E., Espelosin, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00908 · Cited by 90
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice
Chauhan, N. B., & Sandoval, J. (2007) · Phytotherapy Research · doi:10.1002/ptr.2122 · Cited by 89
Braymer, J. J., Choi, J.-S., DeToma, A. S., Wang, C., Nam, K., Kampf, J. W., Ramamoorthy, A., & Lim, M. H. (2011) · Inorganic Chemistry · doi:10.1021/ic2012205 · Cited by 89
Self-citationMethionine regulates copper/hydrogen peroxide oxidation products of Aβ
Ali, F. E. A., Separovic, F., Barrow, C. J., Cherny, R. A., Fraser, F. W., Bush, A. I., Masters, C. L., & Barnham, K. J. (2004) · Journal of Peptide Science · doi:10.1002/psc.626 · Cited by 89
Inhibition of Tau Filament Formation by Conformational Modulation
Akoury, E., Gajda, M. J., Pickhardt, M., Biernat, J., Pornsuwan, S., Griesinger, C., Mandelkow�, E., & Zweckstetter, M. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312471h · Cited by 89
Wu, A. S., Kiaei, M., Aguirre, N., Crow, J. P., Calingasan, N. Y., Browne, S. E., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01639.x · Cited by 88
Regulation of gene expression and its role in long-term memory and synaptic plasticity
Tully, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4239 · Cited by 88
Kański, J., Varadarajan, S., Aksenova, M. V., & Butterfield, D. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00097-7 · Cited by 88
Innocenti, M., Salvietti, E., Guidotti, M., Casini, A., Bellandi, S., Foresti, M. L., Gabbiani, C., Pozzi, A., Zatta, P. F., & Luigi Messori, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1338 · Cited by 87
Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis
Nadjar, Y., Gordon, P., Corcia, P., Bensimon, G., Piéroni, L., Meininger, V., & Salachas, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045034 · Cited by 87
Zavodnik, I. B., Domanski, A. V., Lapshina, E. A., Bryszewska, M. J., & Reiter, R. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.030 · Cited by 87
Wang, Y., Wang, H., & Chen, H. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094820 · Cited by 87
Wang, Z.-M., Cai, P., Liu, Q., Xu, D., Yang, X., Wu, J., Kong, L., & Wang, X. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.052 · Cited by 87
Meng, F.-C., Mao, F., Shan, W., Qin, F., Huang, L., & Li, X. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.029 · Cited by 86
Schilling, S., Appl, T., Hoffmann, T., Cynis, H., Schulz, K., Jagla, W., Friedrich, D., Wermann, M., Buchholz, M., Heiser, U. F., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05471.x · Cited by 86
Phthalocyanine Tetrasulfonates Affect the Amyloid Formation and Cytotoxicity of α-Synuclein
Lee, E.-N., Cho, H.-J., Lee, C.-H., Lee, D., Chung, K. C., & Paik, S. R. (2004) · Biochemistry · doi:10.1021/bi0356707 · Cited by 86
Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., & Marklund, S. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.001 · Cited by 86
A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β Aggregation
Dickens, M. G., & Franz, K. J. (2009) · ChemBioChem · doi:10.1002/cbic.200900597 · Cited by 86
Sirangelo, I., & Iannuzzi, C. (2017) · Molecules · doi:10.3390/molecules22091429 · Cited by 86
Jiang, M., Porat‐Shliom, Y., Pei, Z., Cheng, Y., Xiang, L., Sommers, K., Li, Q., Gillardon, F., Hengerer, B., Berlinicke, C. A., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06752.x · Cited by 85
Characterization of the ZnII Binding to the Peptide Amyloid‐β1–16 linked to Alzheimer's Disease
Mekmouche, Y., Coppel, Y., Hochgräfe, K., Guilloreau, L., Talmard, C., Mazarguil, H., & Faller, P. (2005) · ChemBioChem · doi:10.1002/cbic.200500057 · Cited by 85
Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S. A., Bar‐Am, O., & Youdim, M. B. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.040 · Cited by 85
Xia, Y., Qiang, X., Li, Y., Luo, L., Xu, R., Zheng, Y., Cao, Z., Tan, Z., & Deng, Y. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.02.016 · Cited by 85
“Structural characterization of the minimal segment of TDP-43 competent for aggregation”
Mompeán, M., Buratti, E., Guarnaccia, C., Brito, R. M. M., Chakrabartty, A., Baralle, F. E., & Laurents, D. V. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.007 · Cited by 83
Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents
Li, X., Wang, H., Lu, Z., Zheng, X., Wei Min, N. I., Zhu, J., Fu, Y., Lian, F., Zhang, N., Li, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00636 · Cited by 83
Aliès, B., Eury, H., Bijani, C., Rechignat, L., Faller, P., & Hureau, C. (2011) · Inorganic Chemistry · doi:10.1021/ic201739n · Cited by 82
Darras, F. H., Pockes, S., Huang, G., Wehle, S., Straßer, A., Wittmann, H., Nimczick, M., Sotriffer, C., & Decker, M. W. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn4002126 · Cited by 82
Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease
Youdim, M. B. H., Kupershmidt, L., Amit, T., & Weinreb, O. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70032-4 · Cited by 82
Koh, S. H., Kwon, H., Kim, K. S., Kim, J., Kim, M.-H., Yu, H.-J., Kim, M., Lee, K. W., Rok, B., Jung, H. K., et al. (2004) · Toxicology · doi:10.1016/j.tox.2004.05.008 · Cited by 81
Evidence of Native α-Synuclein Conformers in the Human Brain
Gould, N. S., Mor, D. E., Lightfoot, R. T., Malkus, K. A., Giasson, B. I., & Ischiropoulos, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.538249 · Cited by 80
Hong, L., Carducci, T. M., Bush, W. D., Dudzik, C. G., Millhauser, G. L., & Simon, J. D. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp103272v · Cited by 80
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration
Ramsay, R. R., Májeková, M., Medina, M., & Valoti, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00375 · Cited by 80
Xu, Y., Wang, H., Li, X., Dong, S., Liu, W., Gong, Q., Wang, T., Tang, Y., Zhu, J., Li, J., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.025 · Cited by 80
Zinc-induced dimerization of the amyloid-β metal-binding domain 1–16 is mediated by residues 11–14
Kozin, S. A., Mezentsev, Y. V., Kulikova, A. A., Indeykina, M. I., Golovin, A. V., Ivanov, A. S., Tsvetkov, P. O., & Makarov, A. А. (2011) · Molecular BioSystems · doi:10.1039/c0mb00334d · Cited by 79
Grant, W. B. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2016.1161566 · Cited by 79
Lan, J., Hou, J., Liu, Y., Ding, Y., Zhang, Y., Li, L. J., & Zhang, T. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1256883 · Cited by 79
Hall, G. F., Chu, B., Lee, G. S., & Yao, J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.8.1373 · Cited by 78
Fine, J. M., Baillargeon, A. M., Renner, D. B., Hoerster, N., Tokarev, J. V., Colton, S., Pelleg, A. R., Andrews, A. W., Sparley, K., Krogh, K., et al. (2012) · Experimental Brain Research · doi:10.1007/s00221-012-3101-0 · Cited by 78
Miotto, M., Rodríguez, E. E., Valiente‐Gabioud, A. A., Monserrat, V. T., Binolfi, A., Quintanar, L., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2014) · Inorganic Chemistry · doi:10.1021/ic4031377 · Cited by 78
Tardiff, D. F., Tucci, M. L., Caldwell, K. A., Caldwell, G. A., & Lindquist, S. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308668 · Cited by 78
Electrochemical and theoretical complexation studies for Zn and Cu with individual polyphenols
Esparza, I., Salinas, Í., Santamaría, C., García‐Mina, J. M., & Fernandez-Alvarez, J. M. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.04.029 · Cited by 78
Structural Evidence of Amyloid Fibril Formation in the Putative Aggregation Domain of TDP-43
Mompeán, M., Hervás, R., Xu, Y., Tran, T. H., Guarnaccia, C., Buratti, E., Baralle, F. E., Tong, L., Carrión‐Vázquez, M., McDermott, A. E., et al. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.5b00918 · Cited by 78
Affinity of Cu+ for the Copper-Binding Domain of the Amyloid-β Peptide of Alzheimer’s Disease
Feaga, H. A., Maduka, R. C., Foster, M. N., & Szalai, V. A. (2011) · Inorganic Chemistry · doi:10.1021/ic100967s · Cited by 78
Huang, M. Y., Xie, S., Jiang, N., Lan, J., Kong, L., & Wang, X. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.034 · Cited by 77
Lan, J., Xie, S., Li, S., Pan, L.-F., Wang, X., & Kong, L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.035 · Cited by 77
Hydrogen peroxide can be generated by tau in the presence of Cu(II)
Su, X., Wu, W., Huang, Z., Hu, J. N., Lei, P., Yu, C., Zhao, Y., & Li, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.191 · Cited by 77
Tokuda, E., Ono, S.-I., Ishige, K., Naganuma, A., Ito, Y., & Suzuki, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.09.011 · Cited by 76
Berg, L., Andersson, C. D., Artursson, E., Hörnberg, A., Tunemalm, A., Linusson, A., & Ekström, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026039 · Cited by 76
An update on drug treatment options of Alzheimer's disease
Allgaier, M., & Allgaier, C. (2014) · Frontiers in bioscience · doi:10.2741/4285 · Cited by 76
Chen, X., Zenger, K., Lupp, A., Kling, B., Heilmann, J., Fleck, C., Kraus, B., & Decker, M. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300246n · Cited by 76
Greenough, M. A., Volitakis, I., Li, Q., Laughton, K. M., Evin, G. M., Ho, M., Dalziel, A. H., Camakaris, J., & Bush, A. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163964 · Cited by 76
Ikeda, K., & Iwasaki, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140316 · Cited by 76
Branch, S. Y., Chen, C., Sharma, R., Lechleiter, J. D., Li, S., & Beckstead, M. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1395-15.2016 · Cited by 76
Benchekroun, M., Bartolini, M., Egea, J., Romero, A., Soriano, E., Pudlo, M., Luzet, V., Andrisano, V., Jimeno, M. L., López, M. G., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402409 · Cited by 75
Zirah, S., Rebuffat, S., Kozin, S. A., Debey, P., Fournier, F., Lesage, D., & Tabet, J. (2003) · International Journal of Mass Spectrometry · doi:10.1016/s1387-3806(03)00221-5 · Cited by 75
Copper(II) interaction with amyloid-β: Affinity and speciation
Arena, G., Pappalardo, G., Sóvágó, I., & Rizzarelli, E. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.012 · Cited by 75
Chen, Z., Digiacomo, M., Tu, Y., Gu, Q., Wang, S., Yang, X., Chu, J., Chen, Q., Han, Y., Chen, J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.052 · Cited by 75
Li, Y., Qiang, X., Luo, L., Xia, Y., Xiao, G., Liu, Q., Ai, J., Tan, Z., & Deng, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.009 · Cited by 75
Bourassa, M. W., Brown, H. H., Borchelt, D., Vogt, S., & Miller, L. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00110 · Cited by 74
Meuvis, J., Gérard, M., Desender, L., Baekelandt, V., & Engelborghs, Y. (2010) · Biochemistry · doi:10.1021/bi1010927 · Cited by 74
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial
Weintraub, D. A., Hauser, R. A., Elm, J. J., Pagán, F., Davis, M. D., Choudhry, A., & for the MODERATO Investigators (2016) · Movement Disorders · doi:10.1002/mds.26617 · Cited by 74
Novel Radioiodinated Aurones as Probes for SPECT Imaging of β-Amyloid Plaques in the Brain
Maya, Y., Ono, M., Watanabe, H., Haratake, M., Saji, H., & Nakayama, M. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8003292 · Cited by 73
Smith, N. W., Alonso, A. L. M., Brown, C. M., & Dzyuba, S. V. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.091 · Cited by 73
Xiao, G., Li, Y., Qiang, X., Xu, R., Zheng, Y., Cao, Z., Luo, L., Xia, Y., Sang, Z., Su, F., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.013 · Cited by 73
Tau cleavage and tau aggregation in neurodegenerative disease
Hanger, D. P., & Wray, S. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381016 · Cited by 72
Leuma Yona, R., Mazères, S., Faller, P., & Gras, E. (2008) · ChemMedChem · doi:10.1002/cmdc.200700188 · Cited by 72
Beck, M. W., Oh, S. B., Kerr, R. A., Lee, H. J., Kim, S., Kim, S., Jang, M., Ruotolo, B. T., Lee, J., & Lim, M. H. (2015) · Chemical Science · doi:10.1039/c4sc03239j · Cited by 72
Self-citationHamuľaková, S., Poprac, P., Jomová, K., Brezová, V., Lauro, P., Droštinová, L., Jun, D., Šepsová, V., Hrabinová, M., Soukup, O., et al. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.05.001 · Cited by 72
Hepnarová, V., Korábečný, J., Matoušková, L., Jošt, P., Múčková, Ľ., Hrabinová, M., Vykoukalova, N., Kerhartova, M., Kucera, T., Doležal, R., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.083 · Cited by 72
Prasanthi, J. R. P., Schrag, M., Dasari, B., Marwarha, G., Dickson, A., Kirsch, W. M., & Ghribi, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111346 · Cited by 71
Zinc induces depletion and aggregation of endogenous TDP-43
Caragounis, A., Price, K. A., Soon, C. P. W., Filiz, G., Masters, C. L., Li, Q., Crouch, P. J., & White, A. R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.035 · Cited by 71
Patel, S. D., Meilandt, W. J., Erickson, R. I., Chen, J., Deshmukh, G. S., Estrada, A. A., Fuji, R. N., Gibbons, P., Gustafson, A. E., Harris, S. F., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00843 · Cited by 71
Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro
Ruzza, P., Siligardi, G., Hussain, R., Marchiani, A., Islami, M., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sechi, M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400149k · Cited by 70
Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
Berk, C., & Sabbagh, M. N. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0108-6 · Cited by 70
Levodopa in Parkinson's disease: from the past to the future
Pezzoli, G., & Zini, M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003598919 · Cited by 70
Derrick, J. S., Kerr, R. A., Nam, Y., Oh, S. B., Lee, H. J., Earnest, K. G., Suh, N., Peck, K. L., Özbil, M., Korshavn, K. J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10043 · Cited by 70
Self-citationPPAR-γ: Therapeutic Prospects in Parkinson's Disease
Carta, A. R. (2013) · Current Drug Targets · doi:10.2174/1389450111314070004 · Cited by 70
Polidori, M., & Nelles, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660706 · Cited by 69
Mechanistic Insights into Tunable Metal-Mediated Hydrolysis of Amyloid-β Peptides
Derrick, J. S., Lee, J., Lee, S. J. C., Kim, Y., Nam, E., Tak, H., Kang, J., Lee, M., Kim, S. H., Park, K., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09681 · Cited by 69
Self-citationTau Aggregation in Alzheimer's Disease: What Role for Phosphorylation?
Lippens, G., Sillen, A., Landrieu, I., Amniai, L., Sibille, N., Barbier, P., Leroy, A., Hanoulle, X., & Wieruszeski, J.-M. (2007) · Prion · doi:10.4161/pri.1.1.4055 · Cited by 68
Digiacomo, M., Chen, Z., Wang, S., Lapucci, A., Macchia, M., Yang, X., Chu, J., Han, Y., Pi, R., & Rapposelli, S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.084 · Cited by 68
Inhibition of Amyloid β Aggregation by Acteoside, a Phenylethanoid Glycoside
Kurisu, M., Miyamae, Y., Murakami, K., Han, J., Isoda, H., Irie, K., & Shigemori, H. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.130101 · Cited by 68
Advances in GBA-associated Parkinson's disease – Pathology, presentation and therapies
Barkhuizen, M., Anderson, D. G., & Grobler, A. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.12.004 · Cited by 68
Korshavn, K. J., Jang, M., Kwak, Y. J., Kochi, A., Vertuani, S., Bhunia, A., Manfredini, S., Ramamoorthy, A., & Lim, M. H. (2015) · Scientific Reports · doi:10.1038/srep17842 · Cited by 68
Self-citationMatheou, C. J., Younan, N. D., & Viles, J. H. (2014) · Biochemical Journal · doi:10.1042/bj20141168 · Cited by 68
Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity
Jha, N. N., Ghosh, D., Das, S., Arunagiri, A., Jacob, R. S., Singh, P. K., Ayyagari, N., Namboothiri, I. N. N., & Maji, S. K. (2016) · Scientific Reports · doi:10.1038/srep28511 · Cited by 68
Amyloid-β Peptide Fibrils Induce Nitro-Oxidative Stress in Neuronal Cells
ILL‐Raga, G., Ramos‐Fernández, E., Guix, F. X., Tajes, M., Bosch-Morató, M., Palomer, E., Godoy, J. A., Belmar, S., Cerpa, W. F., Simpkins, J. W., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100474 · Cited by 67
Redox Properties of Met35in Neurotoxic β-Amyloid Peptide. A Molecular Modeling Study
Pogocki, D., & Schöneich, C. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0101550 · Cited by 67
He, Y., Yao, P.-F., Chen, S.-B., Huang, Z., Huang, S., Tan, J., Li, D., Gu, L., & Huang, Z. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.014 · Cited by 67
Modeling the Cu+ Binding in the 1−16 Region of the Amyloid-β Peptide Involved in Alzheimer’s Disease
Furlan, S., Hureau, C., Faller, P., & Penna, G. L. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp102928h · Cited by 67
Camponeschi, F., Valensin, D., Tessari, I., Bubacco, L., Dell’Acqua, S., Casella, L., Monzani, E., Gaggelli, E., & Valensin, G. (2013) · Inorganic Chemistry · doi:10.1021/ic302050m · Cited by 67
The N‐Terminal Domain of ALS‐Linked TDP‐43 Assembles without Misfolding
Tsoi, P. S., Choi, K., Leonard, P. G., Sizovs, A., Moosa, M. M., MacKenzie, K. R., Ferreon, J. C., & Ferreon, A. C. M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706769 · Cited by 67
Kumar, V., Singh, D., Singh, B. K., Singh, S., Mittra, N., Jha, R. R., Patel, D. K., & Singh, C. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3239-y · Cited by 67
Cao, Z., Yang, J., Xu, R., Song, Q., Zhang, X., Liu, H., Qiang, X., Li, Y., Tan, Z., & Deng, Y. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.030 · Cited by 67
Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66
Mitochondrial Involvement in Amyotrophic Lateral Sclerosis: Trigger or Target?
Bacman, S. R., Bradley, W. G., & Moraes, C. T. (2006) · Molecular Neurobiology · doi:10.1385/mn:33:2:113 · Cited by 66
Zhu, J., Yang, H., Chen, Y., Lin, H., Li, Q., Mo, J., Bian, Y., Pei, Y., & Sun, H. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1430691 · Cited by 66
Lincoln, K. M., Gonzalez, P., Richardson, T. E., Julovich, D. A., Saunders, R. E., Simpkins, J. W., & Green, K. N. (2013) · Chemical Communications · doi:10.1039/c2cc36808k · Cited by 66
Yan, J., Hu, J., Liu, A., He, L., Li, X., & Wei, H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.048 · Cited by 65
Li, Y., Qiang, X., Luo, L., Li, Y., Xiao, G., Tan, Z., & Deng, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.012 · Cited by 65
Mohamed, T., Yeung, J. C. K., Vasefi, M., Beazely, M. A., & Rao, P. P. N. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.077 · Cited by 64
NMR and CD studies on the interaction of Alzheimer β-amyloid peptide (12–28) with β-cyclodextrin
Qin, X., Abe, H., & Nakanishi, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02337-9 · Cited by 64
Imaging synaptic zinc: promises and perils
Kay, A. R. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.02.004 · Cited by 64
Is Axonal Degeneration a Key Early Event in Parkinson’s Disease?
Kurowska, Z., Kordower, J. H., Stoessl, A. J., Burke, R. E., Brundin, P., Yue, Z., Brady, S. T., Milbrandt, J., Trapp, B. D., Sherer, T., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160881 · Cited by 64
Hsu, C.-Y., Hung, C.-S., Chang, H.-M., Liao, W.-C., Ho, S.-C., & Ho, Y.-J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.023 · Cited by 63
Mao, F., Huang, L., Luo, Z., Liu, A., Lu, C., Xie, Z., & Li, X. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.045 · Cited by 63
Wang, B., Mai, Y.-C., Li, Y., Hou, J., Huang, S., Ou, T., Tan, J., An, L., Li, D., & Gu, L. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.12.044 · Cited by 63
Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis
Mizuno, Y., Amari, M., Takatama, M., Aizawa, H., Mihara, B., & Okamoto, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0122-4 · Cited by 62
Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes
Parker, S. J., Meyerowitz, J., James, J. L., Liddell, J. R., Nonaka, T., Hasegawa, M., Kanninen, K. M., Lim, S., Paterson, B. M., Donnelly, P. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042277 · Cited by 62
Sheng, R., Tang, L., Jiang, L., Hong, L., Shi, Y., Zhou, N., & Hu, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00224 · Cited by 61
Fine, J. M., Renner, D. B., Forsberg, A. C., Cameron, R. A., Galick, B. T., Le, C., Conway, P. M., STROEBEL, B. M., Frey, W. H., & Hanson, L. R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.013 · Cited by 61
Valiente‐Gabioud, A. A., Monserrat, V. T., Molina-Rubino, L., Binolfi, A., Griesinger, C., & Fernández, C. O. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.011 · Cited by 61
The Aggregated State of Amyloid‐β Peptide In Vitro Depends on Cu2+ Ion Concentration
Jun, S., & Saxena, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700318 · Cited by 61
Li, F., Wu, J., Wang, J., Yang, X., Cai, P., Liu, Q., Kong, L., & Wang, X. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.027 · Cited by 61
An N-Heterocyclic Amine Chelate Capable of Antioxidant Capacity and Amyloid Disaggregation
Lincoln, K. M., Richardson, T. E., Rutter, L., Gonzalez, P., Simpkins, J. W., & Green, K. N. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300060v · Cited by 60
Knez, D., Brus, B., Coquelle, N., Sosič, I., Šink, R., Brazzolotto, X., Mravljak, J., Colletier, J., & Gobec, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.010 · Cited by 60
Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid
Leal, S. S., Cardoso, I., Valentine, J. S., & Gomes, C. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470740 · Cited by 60
Kański, J., Aksenova, M. V., & Butterfield, D. A. (2002) · Neurotoxicity Research · doi:10.1080/10298420290023945 · Cited by 60
Probing copper/tau protein interactions electrochemically
Martic, S., Rains, M. K., & Kraatz, H.-B. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.07.015 · Cited by 60
Wang, X., Xia, C., Chen, S.-B., Tan, J., Ou, T., Huang, S., Li, D., Gu, L., & Huang, Z. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.018 · Cited by 60
Tõugu, V., & Palumaa, P. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.12.008 · Cited by 60
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors
Legoabe, L. J., Petzer, A., & Petzer, J. P. (2012) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2012.08.003 · Cited by 60
Xie, S., Chen, J., Li, X., Su, T., Wang, Y., Wang, Z., Huang, L., & Li, X. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.009 · Cited by 60
Mulligan, V. K., Kerman, A., Laister, R. C., Sharda, P. R., Arslan, P. E., & Chakrabartty, A. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.04.016 · Cited by 60
The neuroprotective role of melatonin against amyloidβpeptide injected mice
Masilamoni, J. G., Jesudason, E. P., Dhandayuthapani, S., Ashok, B. S., Vignesh, S., Walter, C. E. J., Paul, S. F. D., & Rajadas, J. (2008) · Free Radical Research · doi:10.1080/10715760802277388 · Cited by 60
Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz, I., Dziewulska, D., & Kwieciński, H. (2004) · PubMed · Cited by 60
Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy
Sekhar, A., Rumfeldt, J., Broom, H. R., Doyle, C., Sobering, R. E., Meiering, E. M., & Kay, L. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611418113 · Cited by 60
Okuda, M., Fujita, Y., Hijikuro, I., Wada, M., Uemura, T., Kobayashi, Y., Waku, T., Tanaka, N., Nishimoto, T., Izumi, Y., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161017 · Cited by 60
Structure−Activity Relationship of Cyanine Tau Aggregation Inhibitors
Chang, E. S., Congdon, E. E., Honson, N. S., Duff, K., & Kuret, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900116d · Cited by 59
The T-type calcium channel as a new therapeutic target for Parkinson’s disease
Yang, Y., Tai, C., Pan, M., & Kuo, C. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1466-6 · Cited by 59
Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties
Marchiani, A., Mammi, S., Siligardi, G., Hussain, R., Tessari, I., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sanna, D., et al. (2013) · Amino Acids · doi:10.1007/s00726-013-1503-3 · Cited by 59
Butini, S., Campiani, G., Borriello, M., Gemma, S., Panico, A., Persico, M., Catalanotti, B., Ros, S., Brindisi, M., Agnusdei, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701253t · Cited by 59
Chen, Y. R., Huang, H., Chyan, C. L., Shiao, M. S., Lin, T. H., & Chen, Y. C. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj083 · Cited by 58
DeToma, A. S., Krishnamoorthy, J., Nam, Y., Lee, H. J., Brender, J., Kochi, A., Lee, D., Onnis, V., Congiu, C., Manfredini, S., et al. (2014) · Chemical Science · doi:10.1039/c4sc01531b · Cited by 58
Self-citationLarbig, G., Pickhardt, M., Lloyd, D. G., & Schmidt, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077250 · Cited by 58
Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort
Foubert‐Samier, A., Helmer, C., Perez, F., Goff, M. L., Auriacombe, S., Elbaz, A., Dartigues, J., & Tison, F. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25ce · Cited by 57
Dang, T. N. T., Lim, N. K.-H., Grubman, A., Li, Q., Volitakis, I., White, A. R., & Crouch, P. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00015 · Cited by 57
Fedorova, T. D., Knudsen, C. S., Mouridsen, K., Nexø, E., & Borghammer, P. (2015) · Parkinson s Disease · doi:10.1155/2015/156479 · Cited by 57
Zhu, B., Antholine, W. E., & Frei, B. B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00847-x · Cited by 57
Bag, S., Ghosh, S., Tulsan, R., Sood, A., Zhou, W., Schifone, C., Foster, M. C., LeVine, H., Török, B., & Török, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.103 · Cited by 56
Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Merkel, M., Böhmerle, K., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2009) · Dalton Transactions · doi:10.1039/b918439b · Cited by 56
Alzheimer’s disease drug discovery targeted to the APP mRNA 5′Untranslated region
Rogers, J. T., Randall, J., Eder, P. S., Huang, X., Bush, A. I., Tanzi, R. E., Venti, A., Payton, S. M., Giordano, T., Nagano, S., et al. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0014-6 · Cited by 56
Keri, R. S., Quintanova, C., Chaves, S., Silva, D. F., Cardoso, S. M., & Santos, M. A. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12633 · Cited by 56
Prasad, A., Raju, G., Sivalingam, V., Girdhar, A., Verma, M., Vats, K., Taneja, V., Prabusankar, G., & Patel, B. K. (2016) · Scientific Reports · doi:10.1038/srep39490 · Cited by 56
Hong, L., Bush, W. D., Hatcher, L. Q., & Simon, J. D. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075747r · Cited by 55
Xu, J., Wei, C., Xu, C., Bennett, M. C., Zhang, G., Li, F., & Tao, E. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.074 · Cited by 55
Petri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04604.x · Cited by 55
Redler, R. L., Fee, L. R., Fay, J. M., Caplow, M., & Dokholyan, N. V. (2014) · Biochemistry · doi:10.1021/bi500158w · Cited by 55
Li, F., Wang, Z., Wu, J., Wang, J., Xie, S., Lan, J., Xu, W., Kong, L., & Wang, X. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1201814 · Cited by 55
Yedlapudi, D., Joshi, G. S., Luo, D., Todi, S. V., & Dutta, A. K. (2016) · Scientific Reports · doi:10.1038/srep38510 · Cited by 55
Liu, Z., Fang, L., Zhang, H., Gou, S., & Chen, L. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.049 · Cited by 55
Phosphorylation of Ser8 promotes zinc-induced dimerization of the amyloid-β metal-binding domain
Kulikova, A. A., Tsvetkov, P. O., Indeykina, M. I., Popov, I. A., Zhokhov, S. S., Golovin, A. V., Polshakov, V. I., Kozin, S. A., Nudler, E., & Makarov, A. А. (2014) · Molecular BioSystems · doi:10.1039/c4mb00332b · Cited by 54
TAU Aggregation is a Therapeutic Target for Alzheimers Disease
Takashima, A. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611600 · Cited by 54
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Tam, K., & Ju, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.320970 · Cited by 395
Metadata
- Authors
- Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-08-10
- Volume
- 119
- Issue
- 2
- Pages
- 1221-1322
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2886819196
- Cited by
- 581
- References
- 1,155
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.